GOLDSTEIN JOSEPH L
SEC CIK 1225474 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 6,703 | — | $8.78M | 13 | 2021-09-10 | 2026-01-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
| 15 | GOLDSTEIN JOSEPH L | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +155 | 6,703 | +2% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +166 | 6,548 | +3% | $0 |
| D | 2024-01-25 | 2024-01-23 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | M - OptEx | $625.60 | +2,707 | 9,089 | +42% | +$1.69M |
| D | 2024-01-25 | 2024-01-23 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | S - Sale+OE | $950.00 | -2,707 | 6,382 | -30% | -$2.57M |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +135 | 6,382 | +2% | $0 |
| D | 2023-02-08 | 2023-02-06 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | M - OptEx | $482.68 | +3,613 | 9,860 | +58% | +$1.74M |
| D | 2023-02-08 | 2023-02-06 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | S - Sale+OE | $800.00 | -3,613 | 6,247 | -37% | -$2.89M |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +165 | 6,247 | +3% | $0 |
| D | 2022-04-01 | 2022-03-30 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | M - OptEx | $374.12 | +2,431 | 8,513 | +40% | +$909.5K |
| D | 2022-04-01 | 2022-03-30 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | S - Sale+OE | $700.00 | -2,431 | 6,082 | -29% | -$1.70M |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +191 | 6,082 | +3% | $0 |
| D | 2021-09-13 | 2021-09-10 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | M - OptEx | $380.95 | +2,479 | 8,370 | +42% | +$944.4K |
| D | 2021-09-13 | 2021-09-10 | REGN | Regeneron Pharmaceuticals | GOLDSTEIN JOSEPH L | Dir | S - Sale+OE | $650.00 | -2,479 | 5,891 | -30% | -$1.61M |
Purchase Sale Sale after option exercise All abbreviations